Insider Trading activities at Turnstone Biologics Corp. (TSBX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Turnstone Biologics Corp. (TSBX) since 2023 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Turnstone Biologics Corp.. Table 2 shows the detailed insider transactions. This company's CIK number is 1764974.

Total stock buying since 2023: $15,399,984.
Total stock sales since 2023: $0.
Total stock option exercises since 2023: $0.


4 insiders reported insider trading activities at Turnstone Biologics Corp. (TSBX):
Insider trading activities of Jerel Davis
Insider trading activities of Gupta Rishi
Insider trading activities of Orbimed Capital Gp Vi Llc
Insider trading activities of Versant Vantage Ii, L.p.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Turnstone Biologics Corp. (TSBX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2023 1,283,332 $15,399,984 0 $0 0 $0

Table 2. Monthly summary of insider trading at Turnstone Biologics Corp. (TSBX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2023-07 1,283,332 $15,399,984 0 $0 0 $0

Table 3. Detailed insider trading at Turnstone Biologics Corp. (TSBX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2023-07-25 Versant Vantage Ii, L.p. (10% Owner) Buy 225,000 12.00 2,700,000
2023-07-25 Jerel Davis (Director) Buy 225,000 12.00 2,700,000
2023-07-20 Orbimed Capital Gp Vi Llc Buy 416,666 12.00 4,999,992
2023-07-20 Gupta Rishi Buy 416,666 12.00 4,999,992

Insider trading activities including stock purchases, stock sales, and option exercises of TSBX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Turnstone Biologics Corp. (symbol TSBX, CIK number 1764974) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.